^
2ms
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia (clinicaltrials.gov)
P1, N=15, Not yet recruiting, Institute of Hematology & Blood Diseases Hospital, China
New P1 trial
|
cyclophosphamide • RD13-02
over1year
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
New P1 trial
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
almost2years
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02